PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 20, 2026American Journal of Respiratory and Critical Care Medicine1 citations

A34-05 Blood Eosinophil Dynamics in COPD: Impact of Exacerbations and Corticosteroid Use in a Nationwide Study

View Full Paper
MBM BorgOHO HilbergRIR Ibsen

Key Points

  • This study aimed to understand the variability of blood eosinophils in COPD patients and the factors influencing their instability.
  • Nationwide register-based cohort study of 63,517 COPD patients with at least four eosinophil measurements over 3.4 years of follow-up.
  • Categorization of eosinophil levels into three groups: <0.15, 0.15-0.29, and ≥0.30 ×10^9/L.
  • Logistic regression used to identify predictors of eosinophil stability, adjusting for multiple clinical factors.
  • 74% of patients transitioned between eosinophil categories at least once, with only 26% showing stable eosinophil profiles.
  • High baseline eosinophil counts (≥0.30 ×10^9/L) predictive of stability (OR 1.70, 95% CI 1.63-1.77).
  • Over 80% of shifts in eosinophil levels occurred without severe exacerbations or corticosteroid use.

Abstract

Abstract Background Blood eosinophil counts are pivotal for guiding advanced therapies in Chronic Obstructive Pulmonary Disease (COPD), yet their long-term consistency is poorly understood. This study aimed to characterize the longitudinal variability of blood eosinophils and identify factors associated with their instability within a large, real-world COPD population. Methods We conducted a nationwide, register-based cohort study of 63,517 Danish patients with COPD, each with at least four eosinophil measurements over a median follow-up of 3.4 years. Eosinophil levels were categorized into three groups: 0.15, 0.15-0.29, and ≥0.30 ×109/L. We used logistic regression, adjusting for multiple clinical variables including age, sex, comorbidities, and treatments, to determine predictors of stability. Patient transitions between eosinophil categories were visualized using Sankey diagrams. Findings A significant majority of patients (74%) transitioned between eosinophil categories at least once, with only 26% exhibiting a stable eosinophil profile throughout the follow-up period. While a high baseline eosinophil count (≥0.30 ×109/L) was a predictor of stability (OR 1.70, 95% CI 1.63-1.77), eosinophil counts were highly variable overall. Although severe exacerbations and treatment with oral corticosteroids or antibiotics were associated with shifts in eosinophil levels, over 80% of these shifts occurred in the absence of such clinical events. Among patients with unstable counts, 39.7% changed category once, 43.2% twice, and 17.1% three times. Interpretation In patients with COPD, blood eosinophil counts demonstrate substantial long-term variability, often independent of acute clinical events. Consequently, relying on a solitary measurement to guide therapeutic decisions may be insufficient. Serial monitoring of eosinophil counts could offer a more reliable method for identifying patients with persistent type 2 inflammation who are most likely to respond to targeted therapies. This abstract is funded by: Sanofi

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Borg et al. (2026) studied this question.

synapsesocial.com/papers/6a0d5064f03e14405aa9c32ahttps://doi.org/10.1093/ajrccm/aamag162.1623
Ask AI
Helpful
Bookmark
Share
View Full Paper